Kang YM, Cho HK, Kim HM, Lee MH, To TL, Kang HM. Protective efficacy of vaccines of the Korea national antigen bank against the homologous H5Nx clade 2.3.2.1 and clade 2.3.4.4 highly pathogenic avian influenza viruses. Vaccine. 2019 Oct 25
The occurrence of severe outbreaks of highly pathogenic avian influenza in Korea led to establishment of a national antigen bank for emergency preparedness. Here, we developed five vaccines for this bank (clade 2.3.2.1C, clade 2.3.4.4A, B, C, and D) by reverse genetics, inactivated them with formalin, and evaluated the protective efficacy and potency of serial dilutions against lethal homologous challenge in specific-pathogen-free chickens. After vaccination with one dose, each vaccine resulted in 100% survival, with no clinical symptoms, or lack of detectable virus shedding, and high levels of pre-challenge protective immunity (8.4-10.2 log2). After vaccination with one-tenth of the full dose, protection was similar to that with the full dose. After vaccination with one-hundredth of the initial dose, survival was 20-80%, and all vaccines showed virus shedding. Four vaccines (excluding clade 2.3.2.1C) had satisfactory potency. In antibody-persistence tests, all vaccines maintained long-lasting protective immunity. Our results suggest that inactivated reverse-genetics vaccines genetically matched to outbreak viruses provide adequate protection after a single vaccination.
See Also:
Latest articles in those days:
- Current and prospective control strategies of influenza A virus in swine 4 hours ago
- Surveillance and sequestration strategies to reduce the likelihood of transporting HPAIV contaminated layer manure 4 hours ago
- The effect of influenza virus infection on pregnancy outcomes: A systematic review and meta-analysis of cohort studies 4 hours ago
- Nonsense-mediated mRNA decay does not restrict influenza A virus propagation 4 hours ago
- Detection of novel reassortant H9N2 avian influenza viruses in wild birds in Jiangxi Province, China 4 hours ago
[Go Top] [Close Window]